Myriad Genetics Stock Plunges After Supreme Court Loss The stock of Myriad Genetics plunged after the Supreme Court rejected its effort to patent a human gene mutation that is linked to cancer and is common among Ashkenazi Jews. Click here for the rest of the article...
June 14, 2013 - The Forward